Nicox (FRA:NXOA) OCF Margin %: 0.00% (As of Dec. 2025)


FRA:NXOA Nicox SA FRA:NXOA
36 GF Score
Price €0.29
GF Value €0.56
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Nicox OCF Margin %?

Nicox FRA:NXOA -12.01% 36 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates FRA:NXOA with a GF Score™ of 36/100 and a GF Value™ of €0.56 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, Nicox ranks worse than 104166.56% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Nicox's Cash Flow from Operations for the six months ended in Dec. 2025 was €0.00 Mil. Nicox's Revenue for the six months ended in Dec. 2025 was €15.25 Mil. Therefore, Nicox's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Nicox's current OCF Yield % is 0.00%.

The historical rank and industry rank for Nicox's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of Nicox was -37.38%. The lowest was -160712.50%. And the median was -215.32%.

FRA:NXOA's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Nicox OCF Margin % Related Terms

Nicox OCF Margin % Historical Data

* Premium members only.

The historical data trend for Nicox's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nicox OCF Margin % Chart

Nicox Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -215.32 -441.15 0.00 0.00 0.00

Nicox Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:NXOA
36GF Score
Nicox SA FRA:NXOA
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nicox OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Nicox's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=0/16.771
=0.00 %

Nicox's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/15.245
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Nicox (FRA:NXOA) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nicox and its competitors. According to the industry distribution chart, Nicox ranks #999999 out of 960 companies in the Biotechnology industry.
Is Nicox's OCF Margin % too high?
Nicox's current OCF Margin % is 0.00%. Based on the distribution chart, Nicox ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Nicox has a GF Score™ of 36/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nicox's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nicox ranks #999999 out of 960 companies for OCF Margin %. This places Nicox in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Nicox and its competitors. Nicox's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nicox stock overvalued right now?
Based on GuruFocus' analysis, Nicox (FRA:NXOA) is currently considered Possible Value Trap. The stock's GF Value™ is €0.56, compared to a current price of €0.29 — trading 47.7% below its estimated fair value. The current OCF Margin % is 0.00%. Nicox's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Nicox (FRA:NXOA), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nicox (FRA:NXOA) Overvalued in 2026?

Based on GuruFocus' analysis, Nicox stock appears to be undervalued. The current stock price of €0.29 is trading 47.7% below its estimated GF Value™ of €0.56. GuruFocus considers Nicox to be Possible Value Trap.

Key valuation signals for FRA:NXOA:

  • OCF Margin %: 0.00%
  • GF Value™: €0.56 vs. price of €0.29 (47.7% below fair value)
  • GF Score™: 36/100 with 2 warning signs

No single metric tells the full story. See the FRA:NXOA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nicox Business Description

Address Rue Evariste Galois, Emerald Square, Batiment C, Sundesk Sophia Antipolis, Biot, FRA, 06410
Nicox SA is an international ophthalmology company developing solutions to help preserve vision and improve ocular health. It is developing a portfolio of treatments targeting glaucoma, diseases of the anterior segment and retinal diseases. A drug candidate (NCX 470) in phase 3 clinical development designed to reduce intraocular pressure ("IOP") in patients with open-angle glaucoma or ocular hypertension. A drug candidate (NCX 1728) in preclinical development for retinal diseases and glaucoma, derived from Nicox's proprietary nitric oxide (NO)-donating research platform. Its products are ZERVIATE, VYZULTA, Naproxcinod, etc.
36GF Score

Get the complete analysis for FRA:NXOA

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.29
Price
€0.56
GF Value